Canada markets closed

Lexicon Pharmaceuticals, Inc. (LXRX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.5800+0.0400 (+2.60%)
At close: 04:00PM EDT
1.5800 0.00 (0.00%)
After hours: 05:43PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
1,204
1,204
139
298
23,995
Cost of Revenue
85
85
0
0
1,929
Gross Profit
1,119
1,119
139
298
22,066
Operating Expenses
Research Development
58,887
58,887
52,816
55,046
153,621
Selling General and Administrative
113,982
113,982
48,083
32,342
47,230
Total Operating Expenses
172,869
172,869
100,899
87,388
200,851
Operating Income or Loss
-171,750
-171,750
-100,760
-87,090
-178,785
Interest Expense
13,101
13,101
2,780
802
14,544
Total Other Income/Expenses Net
-
-
-
-
131,988
Income Before Tax
-177,119
-177,119
-101,944
-87,758
-58,574
Income Tax Expense
-
-
-
0
0
Income from Continuing Operations
-177,119
-177,119
-101,944
-87,758
-58,574
Net Income
-177,119
-177,119
-101,944
-87,758
-58,574
Net Income available to common shareholders
-177,119
-177,119
-101,944
-87,758
-58,574
Basic EPS
-0.62
-
-0.62
-0.60
-0.53
Diluted EPS
-0.62
-
-0.62
-0.60
-0.53
Basic Average Shares
165,733
-
165,733
145,652
110,841
Diluted Average Shares
165,733
-
165,733
145,652
110,841